athersys inc (ATHX:NASDAQ CM)

Executive Profile*

Background*

Dr. Gil Van Bokkelen, Ph.D. serves as an Investment Advisor to Early Stage Partners, a venture capital fund based in Ohio. Dr. Van Bokkelen Co-Founded Athersys, Inc. in October 1995 and has been its Chief Executive Officer since 1995. He served as the President of Athersys, Inc. until May 2006. He also played a fundamental role in developing the SMC technology. He has been the Chairman of Athersys, Inc. since August 2000 and has been its Director since 1995. He has been ... a Director and a Member of Health Section Governing Board at Biotechnology Industry Organization since July 2011. He served as a Member of the Biotechnology Industry Organization (BIO) Emerging Companies Section Board from 2001 to 2004. He served as a Member of the Kent State University Board of Trustees from 2001 to 2004. He is the recipient of numerous awards, including the Ernst & Young Entrepreneur of the Year award and SBN Visionary in Business Award. He is a co-developer of the Synthetic Human Chromosome technology, and has been awarded several patents. Dr. Van Bokkelen holds a Ph.D. in Genetics from Stanford University, a B.A. in Economics from the University of California at Berkeley and a B.A. in Molecular Biology from the University of California at Berkeley.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
ATHX:US	$1.66 USD	-0.05

COMPETITOR COMPENSATION